Comparing clinical outcomes in patients with type 2 diabetes mellitus after ischaemic stroke: Sodium–glucose cotransporter 2 inhibitors users versus non‐users. A propensity score matching National Cohort Study
Our findings indicate significantly lower risks of recurrent IS and all-cause mortality among patients with T2DM receiving SGLT2i treatment. Further studies are required to validate these results and investigate the underlying mechanisms behind the observed effects.
Authors
- Chi‐Cheng Chuang (ORCID: https://orcid.org/0000-0003-1898-7264)
- Hung‐Chi Su (ORCID: https://orcid.org/0000-0001-5438-5864)
- Yung‐Hsin Yeh (ORCID: https://orcid.org/0000-0003-1645-1941)
- Tzu‐Yang Chen (ORCID: https://orcid.org/0009-0009-5295-9997)
- Hsin‐Fu Lee (ORCID: https://orcid.org/0000-0001-6955-2100)
- Lai‐Chu See (ORCID: https://orcid.org/0000-0002-1379-8969)
- Yi‐Hsin Chan (ORCID: https://orcid.org/0000-0002-1406-8503)
- Pei‐Ru Li (ORCID: https://orcid.org/0000-0001-7744-0555)
Institutions
- Chang Gung University (TW)
- Chang Gung Memorial Hospital (TW)
- Taipei City Hospital (TW)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1111/dom.15804
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.36
Funders
- Chang Gung Memorial Hospital